基于超声和超声造影特征鉴别肿块型胰腺炎与胰腺导管腺癌的列线图模型构建与验证
回顾性分析2018年1月至2023年12月接受胰腺超声造影的281例患者,随机分为训练集196例和验证集85例,通过logistic回归筛选出鉴别胰腺导管腺癌与肿块型胰腺炎的独立预测影像特征并构建超声模型和超声联合超声造影模型;联合模型在训练集AUC为0.930(95%CI 0.895-0.965)、验证集为0.914(95%CI 0.853-0.976),校准和临床获益良好。
要点
- 超声联合超声造影列线图模型鉴别胰腺导管腺癌与肿块型胰腺炎训练集AUC 0.930、验证集AUC 0.914。
- 纵径大于横径形状、钙化、廓清模式是鉴别胰腺导管腺癌与肿块型胰腺炎的独立预测因素。
- 校准曲线和Hosmer-Lemeshow检验(P>0.05)显示模型校准良好,决策曲线分析显示显著临床获益。
核心结论
- 基于纵径大于横径形状、钙化和廓清模式构建的列线图模型在鉴别胰腺导管腺癌与肿块型胰腺炎方面表现出优秀的区分能力、准确性和临床实用性。
研究设计与样本
- 回顾性研究,纳入2018年1月至2023年12月接受胰腺超声造影的281例患者,随机分为训练集196例和验证集85例,采用logistic回归筛选独立预测影像特征并构建超声模型和超声联合超声造影模型。
关键影像表现/征象
- 多因素logistic回归显示纵径大于横径形状(P=0.002,OR=0.12)、钙化(P=0.003,OR=13.76)和廓清模式(P=0.002,OR=0.13)是鉴别胰腺导管腺癌与肿块型胰腺炎的独立预测因素。
诊断标准与关键数值
- 超声联合超声造影模型鉴别胰腺导管腺癌与肿块型胰腺炎的AUC在训练集为0.930(95%CI 0.895-0.965),在验证集为0.914(95%CI 0.853-0.976)。
- 校准曲线和Hosmer-Lemeshow检验(P>0.05)确认模型校准良好,决策曲线分析显示显著临床获益。
临床应用与阅片要点
- 作者认为基于纵径大于横径形状、钙化和廓清模式构建的列线图模型在鉴别胰腺导管腺癌与肿块型胰腺炎方面具有优秀的区分能力、准确性和临床实用性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the value of ultrasound (US) and contrast-enhanced ultrasound (CEUS) in differentiating mass-forming Pancreatitis (MFP) and pancreatic ductal adenocarcinoma (PDAC).
METHODS: This retrospective study analyzed clinical and imaging data from 281 patients who underwent pancreatic CEUS between January 2018 and December 2023. Patients were randomly divided into training (n = 196) and validation (n = 85) sets. Logistic regression analyses were conducted to identify independent predictive imaging features for differentiating PDAC from MFP in the training set. Based on the identified predictors, two nomogram models were constructed: the US model and the US + CEUS model. The diagnostic performance of both models was assessed via the area under the receiver operating characteristic curve (AUC), calibration plots, Hosmer-Lemeshow test, and decision-curve analysis (DCA).
RESULTS: Multivariate logistic regression analysis based on these factors identified taller-than-wide shape (P = 0.002, OR = 0.12), calcification (P = 0.003, OR = 13.76), and washout pattern (P = 0.002, OR = 0.13) as independent predictive factors for distinguishing PDAC from MFP. Compared to the US model, the US + CEUS model demonstrated better performance with AUC values 0.930 (95% CI: 0.895-0.965) in the training set and 0.914 (95% CI: 0.853-0.976) in the validation set. Calibration curve plots and the Hosmer-Lemeshow test (P > 0.05) confirmed that the model has good calibration, and DAC showed significant clinical benefit.
CONCLUSION: The nomogram model constructed using taller-than-wide shape, calcification, and washout pattern demonstrated excellent discriminative ability, accuracy, and clinical utility in differentiating PDAC from MFP.
引用
- Liang H, Gui Y, Chen X, et al. Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2025. PMID: 40448846. doi:10.1007/s00261-025-05035-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。